New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo) after bladder cancer surgery reduced their overall risk ...
Jun 4, 2021
0
12
A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning ...
Jun 2, 2021
0
2
May is Bladder Cancer Awareness Month, which makes this a good time to learn more about bladder cancer.
May 18, 2021
0
3
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen ...
Apr 28, 2021
0
13
Marc Baum went through all the usual steps to treat his bladder cancer—a couple of surgeries, radiation therapy and chemotherapy, all in a three-month period.
Apr 13, 2021
0
29
A new research study leveraging a database from the largest equal access health system in the US, the Department of Veteran Affairs, offers insight into the outcome of specific treatment patterns for advanced bladder cancer ...
Apr 1, 2021
0
2
A high rate of genetic mutations within a tumor, known as high tumor mutation burden (TMB), was only useful for predicting clinical responses to immune checkpoint inhibitors in a subset of cancer types, according to a new ...
Mar 15, 2021
1
28
A new analysis of U.S.-funded cancer research shows that online news stories mention significantly fewer studies than do other forms of news media. Additionally, it highlights mismatches between relative prevalence or mortality ...
Mar 10, 2021
0
0
Bladder cancer is more aggressive and more advanced in South Texas residents than in many parts of the country, a study by the Mays Cancer Center, home to UT Health San Antonio MD Anderson, indicates.
Feb 25, 2021
0
2
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of their disease returning and should be adopted as the new standard of care, a new study shows.
Feb 2, 2021
0
7
